Literature DB >> 9043864

A 3-Mb region for the familial hemiplegic migraine locus on 19p13.1-p13.2: exclusion of PRKCSH as a candidate gene. Dutch Migraine Genetic Research Group.

R A Ophoff1, G M Terwindt, M N Vergouwe, R van Eijk, H Mohrenweiser, M Litt, M H Hofker, J Haan, M D Ferrari, R R Frants.   

Abstract

Familial hemiplegic migraine (FHM) is an autosomal domianant subtype of migraine with attacks, associated with transient episodes of hemiparesis. One of the genes for FHM has been assigned to chromosome 19p13. Detailed analysis of critical recombinants from two different chromosome 19-linked FHM families, using new markers indicated a 6-cM candidate region on 19p13.1-p13.2 flanked by loci D19S394 and D19S226. Another paroxysmal neurological disorder, episodic ataxia type 2 (EA-2), has also been linked to the same chromosomal region. Most of the interval was completely covered by YAC and cosmid contigs; the physical map yielded approximately 3 Mb encompassing several genes including the protein kinase substrate 80K-H (PRKCSH) gene. Since PRKCSH is involved in neuronal signal transduction, it was considered to be an FHM candidate gene. The genomic structure of this gene was established and mutation analysis for all exon and flanking intron sequences was performed in FHM- and EA-2-affected individuals. Five polymorphisms were identified, including a trinucleotide repeat length variation in the coding sequence. However, no potential disease causing mutation was found and therefore the PRKCSH gene can be excluded for both FHM and EA-2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9043864

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  6 in total

1.  In situ imaging reveals properties of purinergic signalling in trigeminal sensory ganglia in vitro.

Authors:  Arletta Nowodworska; Arn M J M van den Maagdenberg; Andrea Nistri; Elsa Fabbretti
Journal:  Purinergic Signal       Date:  2017-08-18       Impact factor: 3.765

2.  Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2.

Authors:  M L Kennerson; D Zhu; R J Gardner; E Storey; J Merory; S P Robertson; G A Nicholson
Journal:  Am J Hum Genet       Date:  2001-08-28       Impact factor: 11.025

Review 3.  Ion channelopathies and migraine pathogenesis.

Authors:  Cassie L Albury; Shani Stuart; Larisa M Haupt; Lyn R Griffiths
Journal:  Mol Genet Genomics       Date:  2017-04-07       Impact factor: 3.291

4.  Refined localization of dominant intermediate Charcot-Marie-Tooth neuropathy and exclusion of seven known candidate genes in the region.

Authors:  Danqing Zhu; Marina Kennerson; John Merory; Roman Chrast; Mark Verheijen; Greg Lemke; Garth Nicholson
Journal:  Neurogenetics       Date:  2003-05-22       Impact factor: 2.660

5.  Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2.

Authors:  Loredana Leo; Lisa Gherardini; Virginia Barone; Maurizio De Fusco; Daniela Pietrobon; Tommaso Pizzorusso; Giorgio Casari
Journal:  PLoS Genet       Date:  2011-06-23       Impact factor: 5.917

Review 6.  Involvement of P2X7 receptors in chronic pain disorders.

Authors:  Wen-Jing Ren; Peter Illes
Journal:  Purinergic Signal       Date:  2021-11-20       Impact factor: 3.765

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.